Transcriptomic and epigenetic regulation of disuse atrophy and the return to activity in skeletal muscle. by Fisher, AG et al.
THE
JOURNAL • RESEARCH • www.fasebj.org
Transcriptomic and epigenetic regulation of disuse
atrophy and the return to activity in skeletal muscle
Andrew G. Fisher,*,1 Robert A. Seaborne,†,‡,1 Thomas M. Hughes,§ Alex Gutteridge,{ Claire Stewart,†
Judy M. Coulson,k Adam P. Sharples,†,‡,2 and Jonathan C. Jarvis‡,3
*Institute for Ageing and Chronic Disease and kDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine,
University of Liverpool, Liverpool, United Kingdom; †Institute for Science and Technology in Medicine, Keele University Medical School, Keele
University, Staffordshire, United Kingdom; ‡Stem Cells, Ageing, and Molecular Physiology Research Unit, Exercise Metabolism and
Adaptation Research Group, Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom;
§Instituto de Fı´sica y Astronomı´a, Universidad de Valparaı´so, Valparaı´so, Chile; and {Pfizer, Tadworth, United Kingdom
ABSTRACT: Physical inactivity and disuse are major contributors to age-relatedmuscle loss. Denervation of skeletal
muscle has been previously used as amodel with which to investigate muscle atrophy following disuse. Although
gene regulatory networks that control skeletal muscle atrophy after denervation have been established, the tran-
scriptome in response to the recovery of muscle after disuse and the associated epigenetic mechanisms that may
function to modulate gene expression during skeletal muscle atrophy or recovery have yet to be investigated. We
report that silencing the tibialis anterior muscle in rats with tetrodotoxin (TTX)—administered to the common
peroneal nerve—resulted in reductions in muscle mass of 7, 29, and 51%with corresponding reductions in muscle
fiber cross-sectional area of 18, 42, and 69% after 3, 7, and 14 d of TTX, respectively. Of importance, 7 d of recovery,
during which rodents resumed habitual physical activity, restored muscle mass from a reduction of 51% after
14 d TTX to a reduction of only 24% compared with sham control. Returning muscle mass to levels observed at
7 d TTX administration (29% reduction). Transcriptome-wide analysis demonstrated that 3714 genes were differ-
entially expressed across all conditions at a significance of P £ 0.001 after disuse-induced atrophy. Of interest, after
7 d of recovery, the expressionof genes thatweremost changedduringTTXhad returned to that of the shamcontrol.
The 20most differentially expressed genes after microarray analysis were identified across all conditions andwere
cross-referenced with the most frequently occurring differentially expressed genes between conditions. This gene
subset included myogenin (MyoG), Hdac4, Ampd3, Trim63 (MuRF1), and acetylcholine receptor subunit a1
(Chrna1). Transcript expression of these genes and Fboxo32 (MAFbx), because of its previously identified role in
disuse atrophy together with Trim63 (MuRF1), were confirmed by real-time quantitative RT-PCR, and DNA
methylation of their promoter regionswas analyzed by PCR and pyrosequencing.MyoG, Trim63 (MuRF1), Fbxo32
(MAFbx), and Chrna1 demonstrated significantly decreased DNA methylation at key time points after disuse-
inducedatrophy that correspondedwithsignificantly increasedgeneexpression.Of importance,afterTTXcessation
and 7 d of recovery, there was a marked increase in the DNAmethylation profiles of Trim63 (MuRF1) and Chrna1
back to control levels. This also corresponded with the return of gene expression in the recovery group back to
baseline expression observed in sham-surgery controls. To our knowledge, this is the first study todemonstrate that
skeletal muscle atrophy in response to disuse is accompanied by dynamic epigenetic modifications that are asso-
ciatedwith alterations in gene expression, and that these epigenetic modifications and gene expression profiles are
reversibleafter skeletalmuscle returns tonormalactivity.—Fisher,A.G.,Seaborne,R.A.,Hughes,T.M.,Gutteridge,
A.,Stewart,C.,Coulson, J.M.,Sharples,A.P., Jarvis, J.C.Transcriptomicandepigenetic regulationofdisuseatrophy
and the return to activity in skeletal muscle. FASEB J. 31, 5268–5282 (2017). www.fasebj.org
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Skeletal muscle is the most abundant tissue in the mam-
malian body and, therefore, maintenance of its structure
and function are important to health across the lifespan.
The global maintenance of skeletal muscle mass is gov-
erned by a fine balance between muscle protein synthesis
and degradation. Skeletal muscle undergoes rapid loss—
atrophy—during disuse and inactivity (1–4); catabolic/
inflammatory disease states, such as cancer cachexia (5, 6),
sepsis (7), chronic heart failure (8), and obesity (9); as well
as with denervation after, for example, spinal cord injury
(10) or during aging (sarcopenia) (11). To investigate the
underlying time course and mechanisms of skeletal mus-
cle atrophy, such models as denervation via nerve section
(12), tetrodotoxin (TTX) injection (13), limb suspension
(14), spaceflight (15), and chronic overuse (16, 17) have
been implemented. Within these models, large alterations
in gene regulatory networks may orchestrate the altered
balance between protein synthesis and degradation dur-
ing muscle wasting (18). Under such conditions, these
regulatory networks are altered to favor the breakdownof
skeletal muscle proteins, predominantly via the ubiquitin-
proteasome pathway (19–21). Whereas gene regulatory
networks that control skeletal muscle atrophy have been
somewhat elucidated, the role of epigenetic alterations in
modulating gene expression during skeletal muscle atro-
phyhas received less attention. Furthermore, there are few
studies that have investigated the transcriptomic and
epigenetic change that underlies the recovery of skeletal
muscle after a return to normal physical activity after a
period of disuse.
Epigenetic control of gene expression occurs primarily
as a result of the modification to DNA or chromatin/
histones as well as post-transcriptional modification of
RNA (22). It has recently been suggested thatdenervation-
induced atrophy results in the differential expression of
genes that are associated with chromatin remodeling (23).
Recent in vitro evidence also suggests that epigenetic
mechanisms may influence regeneration and myotube
atrophy (24). Skeletal muscle cells that have encountered
theatrophic stimulusof the inflammatorycytokine,TNF-a,
during their early proliferative life are more susceptible
to TNF-a later in their proliferative life, and demonstrate
impaireddifferentiation and regeneration comparedwith
matched, untreated controls (24). Of importance, in this
study, a retention of DNA methylation of the myogenic
regulatory factor, MyoD was evident over 30 population
doublings inmuscle cells that receive a single acute (24-h)
cytokine stress in early life (24). This study, therefore,
points to a potentially important epigenetic mechanism
that underlies the susceptibility to loss ofmusclemass (25).
Furthermore, recent studies that investigated 44 muscle-
specific genes reported that where low methylation oc-
curred, gene enhancer activity increased (26). Despite this,
it has not been confirmed in vivowhether the modulation
of gene expression via DNA methylation is a mechanism
that regulates skeletal muscle disuse atrophy.
In thepresent study,weusedTTX to silence thenerve to
evoke disuse-induced muscle atrophy. TTX inhibits the
firing of action potentials by binding to the voltage-gated
sodiumchannel innerve cellmembranes,whichblocks the
throughput of sodium ions; therefore, themuscles that are
innervated by the blocked nerve cannot be activated to
contract (27). This model has the advantage over nerve
section in thatTTX causes a complete, but reversible, block
of sodiumchannels and, thus, reversible nerve andmuscle
inactivity. In this study, to investigate both disuse and
recovery, TTX was delivered over a preset period after
which normal nerve activity resumed. After nerve silenc-
ing, DNA microarray technology was used to investigate
the temporal genome-wide transcript expression profiles
associated with progressive atrophy at 3, 7, and 14 d of
disuse. Nerve block was then released, habitual activity
resumed, and gene expression profiles were monitored
after 7 d of recovery. Finally, DNAmethylationwithin the
promoter regions of genes was measured via pyrose-
quencing for genes that demonstrated—via microarray
and confirmatory real-time quantitative RT-PCR (qRT-
PCR)—the most significant alterations in expression
across all conditions and that were most frequently dif-
ferentially expressed across all pairwise comparisons. The
aim of this investigation was, therefore, to elucidate the
epigenetic control of gene expression after disuse atrophy
and a return to normal physical activity in skeletalmuscle.
Wehypothesized that disuse atrophywould be controlled
bydifferentialDNAmethylationand corresponding changes
ingeneexpression, and that thesealterationsperhapswould
be transient anddynamic innatureand, therefore, reversible
as normal muscle activity resumes.
MATERIALS AND METHODS
Animals
Ethics approvalwasobtainedandexperimental procedureswere
conducted with the permissions within a project license granted
under the British Home Office Animals (Scientific Procedures)
Act 1986.MaleWistar rats thatweighed between 350–450 gwere
housed in controlled conditions of 20°C and 45% relative hu-
midity, with food and water available ad libitum. Animals were
assigned to 5 groups that included 1 control group and 3 TTX-
exposedgroups forperiodsof 3, 7, and14d, includinga14-dTTX
exposure plus 7-d active recovery group. Experimental groups
are detailed below and represented schematically in Fig. 1.
Experimental groups
The left commonperoneal nervewas exposed to TTXover preset
time courses. Groups (n = 6) consisted of 3, 7, and 14 d of TTX
exposure and 14 d of TTX followed by 7 d of natural active re-
covery. To control TTX exposure, a miniosmotic pump (Mini
Osmotic Pump2002; Alzet, Cupertino, CA,USA)was implanted
subcutaneously in the scapular region of animals under TTX
conditions. Delivery tubes were subcutaneaously channeled to a
silicone rubber cuff that was carefully placed around the com-
mon peroneal nerve of the left hind limb. Implantation was
performed in-house as amodification of a published design (28).
The osmotic pumpefficientlydelivered 0.5ml/hTTX (350mg/ml
in sterile 0.9% saline) to the nerve cuff, which allowed the com-
mon peroneal nerve to be exposed to TTX so that the ankle
dorsiflexor muscles—tibialis anterior (TA) and extensor dig-
itorum longus—were silenced but normal voluntary plantar-
flexion was maintained. The general welfare and mobility of
group-housed rats were minimally affected. Correct assembly
and loading of the osmotic pump and nerve cuff was planned so
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that TTX administration would terminate after 14 d, which
allowed the recovery of hindlimb function fromd 14 to 21within
the 14-d TTX + 7-d recovery group.
Morphology and histology for muscle size (mass
and cross-sectional area)
At the end of each experimental time course, all animalswere
humanely euthanized with increasing CO2 concentration
and cervical dislocation. For morphologic and histologic
purposes, muscle was harvested from control and experi-
mental groups (n = 6), weighed, and divided into pieces, and
a transverse portion from the midbelly of the muscle was
frozen in melting isopentane, cryostat sectioned (;10 mm),
and stained with hematoxylin and eosin. For each muscle
sample, 5 images were obtained at random. By using ImageJ
1.45i software (National Institutes of Health, Bethesda, MD,
USA), each photograph was overlaid with an 83 8 grid with
which to make an unbiased selection of fibers. Ten fibers
were selected for counting for each field of view at the first 10
intersections of the grid that fell within a fiber. Magnification
of each section was calibrated from an image of a stage
graticule. Cross-sectional area (CSA) was estimated from
precise diameter measurements that were taken by selecting
2 points across the minimum diameter and assuming a cir-
cular cross-section. Mean TA mass for all control and experi-
mental groups was expressed as a percentage of whole animal
body mass (428 6 45 g) to normalize for interindividual differ-
ences in animal size (n = 6). Mean CSA of TA muscle fiber was
expressed as percentage change from theuntreated contralateral
control limb for each animal (n = 6). All data are presented as
means6 SD, unless otherwise stated.
Transcriptome analysis
We conducted microarray analyses to compare genome-wide
transcript expression from3-, 7-, and 14-d TTX and 14-d TTX+ 7-d
recovery groups (n = 4 for each group). Untreated control sam-
ples were also used for quality control of microarray analysis and
were excluded from the final analysis. Frozen muscle samples
were sent to AROS Applied Biotechnology (Aarhus, Denmark),
where RNA was isolated via AROS Standard Operating Proce-
dures.More than 30,000 rat transcripts and 28,000 variants were
examined via Affymetrix GeneChip Rat Genome 230 2.0 Array
(Affymetrix, High Wycombe, United Kingdom). Raw data files
(CEL) were normalized via the MAS 5.0 signal method (29, 30),
and CHP files were subsequently analyzed for significantly dif-
ferential gene expression from microarray data [Transcriptome
Analysis Console (TAC); Affymetrix]. TAC software was used to
create hierarchical clustering heatmaps of the most differentially
expressed genes.
RNA isolation and primer design for real-time
qRT-PCR
RNAwasextracted fromfrozenmuscle tissue (n=6 forall sample
groups) and frozen in RNA storage solution (Qiagen, Man-
chester, United Kingdom). Samples (;20 mg) were immersed
and homogenized in Trizol (Thermo Fischer Scientific,Waltham,
Figure 1. Schematic representation of the TTX muscle atrophy model and subsequent muscle sample preparation for
morphologic, transcriptomic, and epigenetic analysis. A) Display of physiologic location of TTX administration pump. Real
image of osmotic pump location and assembly within the left hindlimb of the rodent (i), and a representation overview of the
osmotic pump assembly (ii; black lines show osmotic pump unit and delivery tube to nerve cuff unit and white line displays
the synaptic nerve). B) Muscle sample preparation for downstream analysis: treated (left) and untreated contralateral control
(right; n = 6).
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MA, USA), and RNA was extracted according to the manufac-
turer’s instructions.Quantities andquality ofRNAwere assessed
by 260/280 UV spectroscopy (Thermo Fisher Scientific). Isolated
RNAproduced an average 260/280 ratio of 1.996 0.02. Primers
were designed with Primer-Basic Local Alignment Search Tool
(BLAST) (National Center for Biotechnology Information,
Bethesda,MD,USA).All designedprimerswerebetween20and
21 bp in length and, where possible, had a guanine-cytosine
content of 50–55%. The software program, netprimer, predicted
the efficiency of the primer products, estimating the probability
of primer dimer or hairpin formation. Primers were manufac-
tured by Sigma-Aldrich (St. Louis, MO, USA) and resuspended
in either Tris-EDTA buffer or RNA-free water (Sigma-Aldrich)
as a 100-mM stock suspension. Details of primer assays are pro-
vided in Table 1.
Real-time qRT-PCR
Real-time qRT-PCRwas performed by using either HotStart Taq
Master Mix Kit (Qiagen) and an iQ5 Thermocycler (Bio-Rad,
Hercules,CA,USA) orQuantiFast SYBRGreenRT-PCRone-step
kit on a Rotorgene 3000Q (Qiagen). cDNA synthesis for sub-
sequent PCRon the iQ5Thermocyclerwasperformedas follows:
1 mg RNA was diluted in 12 ml of RNA-free water, and 1 ml of
oligo dTprimer (Thermo Fisher Scientific)was incubated at 70°C
for 10min and subsequently snap-cooledon ice to enable binding
of the primer. A reaction mix—4 ml of 53 buffer, 2 ml DTT, 1 ml
deoxynucleotides (dNTPs)—were added per RNA sample and
incubated at 42°C for 2 min. One microliter of Superscript II
Reverse Transcriptase (Thermo Fisher Scientific) was then added
and the reaction mix was incubated for an additional 50 min
at 42°C. This reaction was inhibited by then heating to 70°C for
15min.Asacontrol, reactionswereprepared inparallelwith those
previously described for each RNA sample, without the inclusion
of the reverse-transcriptase enzyme so thatmRNAwould not be
reverse transcribed into cDNA. These negative control primers
were used to confirm that the products amplified by PCR were
indeed derived from cDNA. For real-time qPCR using HotStart
Taq Master Mix Kit on the iQ5 Thermocycler, reactions were as
follows: 3 ml cDNA, 15 ml Hotstar Taq Master Mix, and 1.5 ml
eachof forwardandreverseprimerand9ml ofRNase-freewater,
totaling 30ml for reactions. For real-time qPCRusingQuantiFast
SYBR Green RT-PCR One-Step Kit on a Rotorgene 3000Q,
reactions were as follows: 9.5ml RNA sample (7.3 ng/ml = 70 ng
total RNA in the reaction), 0.15 ml of forward primer, 0.15 ml of
reverse primer, 0.20 ml of reverse transcriptase mix, and 10 ml of
SYBR Green buffer (QuantiFast SYBR Green RT-PCR One-Step
Kit; Qiagen), totaling 20 ml. For the QuantiFast SYBR Green RT-
PCR One-Step Kit, reverse transcription cycles were performed
in the same tube/reaction before PCR as follows: hold 50°C for
10min (reverse transcription/cDNAsynthesis), followedby 95°C
for 5 min (transcriptase inactivation and initial denaturation
step), before 40 PCR cycles of 95°C for 10 s (denaturation) and
60°C for 30 s (annealing and extension). Finally, melt curve
analyseswereperformed to identify anyprimerdimer formation
or nonspecific amplification. All melt curves produced single
reproduciblemelt temperatures across all experimental samples.
All relative mRNA expression was quantified by using the
Ct (
DDCt) method (31) against a known reference gene, RPIIb
(polr2b) and/or Rn18s. Average Ct values for RPIIb and Rn18s
were 20.08 6 0.59 and 15.80 6 0.39, respectively, across all ex-
perimental conditions.
DNA isolation and bisulfite conversion
To elucidate methylation profiles, DNA was extracted from fro-
zen muscle tissue by using a commercially available DNA iso-
lation kit (DNA Blood and Muscle Kit; Qiagen) according to
manufacturer instructions. For methylation analysis via high-
resolution melt PCR (HRM-PCR), bisulfite conversion of 2 mg
DNAwas performed by using InnuConvert All-in-One Bisulfite
Conversion kits (AJ Innuscreen GmbH, Berlin, Germany). For
DNA methylation by PCR and pyrosequencing (see Materials
and Methods), 500 ng DNA was bisulfite converted by using a
ZymoResearch EZMethylationKit (ZymoResearch, Irvine, CA,
USA).
DNA methylation by PCR and pyrosequencing
Assays for pyrosequencing were purchased from epigenDX
(Hopkinton,MA,USA; summarized in Fig. 2 andTable 2). After
bisulfite conversion, PCR reactionswere designed depending on
the specificDNAmethylated region of interest and the size of the
product as per the manufacturer’s instructions; however, a typ-
ical reaction was performed as follows: 3 ml of 103 PCR buffer
(containing 15 mM MgCl2), 0.2 ml of 10 mM dNTPs, 1.8 ml of
25 mM MgCl2, 0.6 ml of 10 mM dNTPs, 0.15 ml HotStar Taq
Polymerase, 1ml of bisulfite-treatedDNA,and0.2mMof forward
and reverse primer (Table 2). One primer was biotin-labeled and
HPLC-purified to facilitate the purification of the final PCR
product using Sepharose beads. After an initial denaturation
incubation at 95°C for 15 min, 45 cycles of denaturation at 95°C
for 30 s, 63°C for 30 s (annealing), and 68°C for 30 s (extension)
were performed, with all PCR cycles followed by a final 5min at
68°C. PCR products were then bound to Streptavidin Sepharose
HP (GE Healthcare Life Sciences, Waukesha, WI, USA), after
which the immobilized PCR products were purified, washed,
denatured with a 0.2 mM NaOH solution, and rewashed using
the Pyrosequencing Vacuum Prep Tool (Qiagen) as per manu-
facturer instructions. After annealing with 0.5 mM sequencing
primer, purified single-stranded PCR products were sequenced
by using the PSQ96 HS System (Qiagen) according to manufac-
turer instructions. The methylation status of each CpG site was
determined individually as an artificial C/T single-nucleotide
polymorphismusingQCpG software (Qiagen). Themethylation
TABLE 1. Primer assay design for real-time qRT-PCR
Gene Accession No.
Primer, 59–39
Primer
length (bp)
Optimum
annealing
temperature (°C)
Product
length (bp)Forward Reverse
Trim63 NM_080903 GGAGGAGTTTACTGAAGAGG GACACACTTCCCTATGGTGC 20 61 180
Fbxo32 NM_133521 CTTGTCTGACAAAGGGCAGC TGAAAGTGAGACGGAGCAGC 20 61 184
Ampd3 NM_031544 ACGCTTGCTGGTCGGTTTAG TGGCTTCCTTCTGTCCGATG 20 60 197
Hdac4 XM_343629.4 GCAGCCAAACTTCTCCAGCA TTGACATTGAAACCCACGCC 20 61 212
MyoG NM_017115.2 GCCATCCAGTACATTGAGCG CATATCCTCCACCGTGATGC 20 61 267
Chrna1 NM_024485.1 TGTCATCAACACACACCACC CTGCAATGTACTTCACACCC 20 61 269
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level at each CpG site was calculated as the percentage of
methylated alleles divided by the sum of all methylated and
unmethylatedalleles. Themeanmethylation levelwas calculated
by using themethylation levels of all measured CpG sites within
the targeted region of each gene. Each experiment included
non-CpG cytosines as internal control to detect the in-
complete bisulfite conversion of the input DNA. In addition,
a series of unmethylated and methylated DNA strands were
included as a control after each PCR. Furthermore, PCR bias
testing was performed by mixing unmethylated control
DNA with in vitro methylated DNA at different ratios (0, 5,
10, 25, 50, 75, and 100%), followed by bisulfite modification,
PCR, and pyrosequencing analysis. All supporting in-
formation for gene assays, including assay sequence, chro-
mosomal CpG island locations, position from the ATG start
codon and transcriptional start site, and CpG number are
given in Fig. 2 and Table 2.
HRM-PCR for total DNA methylation
HRM-PCR for CpG methylation was performed as previously
described (24). In brief, 20 ng DNA was subjected to HRM-PCR
using EpiTect HRM-PCR kits and Rotorgene 3000Q (Qiagen)
with Rotorgene software. All primer concentrations for gene
CpGassays and EpiTect HRMmastermix volumeswere used in
accordance with manufacturer instructions. HDAC4 (Qiagen)
was designed to amplify a product length of 140–190 bp
(Table 3). PCR cycles were performed as follows: 10 s at 95°C
(denaturation), 30 s at 55°C (annealing), and 10 s at 72°C
Figure 2. Gene map of CpG islands for locus-speciﬁc pyrosequencing for quantiﬁcation of DNA methylation via pyrosequencing.
In descending order: MyoG, Fboxo32 (MAFbx), Trim63 (MuRF1), Ampd3, and Chrna1. URT, untranslated region.
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(extension) for a maximum of 55 cycles. After PCR, an HRM
analysis was performed with 0.1°C increments from 65°C to
95°C. Fluorescence vs. melt temperature was used to create a
standard curve using rat methylated DNA standards that rep-
resented 100, 75, 50, 25, 10, 5, and 0% methylation. All samples
were run in duplicate and were normalized to 0% methylated
control and averaged to produce a single curve. The relationship
between the area under the curve—determined via each stan-
dard curve—and the corresponding percentage methylation
curve of specific gene loci was determined by using the best-
fitting fourth-order polynomial relation. This relationship was
subsequently used to quantify the percentage methylation from
the integrated raw melt curves of the experimental samples.
Calculationswereperformedbyusing aPython-basedprogram,
MethylCal, that was developed for this purpose in-house [used
previously (24)].
Statistical analyses
All statistical analyses of morphologic data were performed via
either R software (v.2.13.1; http://www.R-project.org) or SPSS
(v.22.0; SPSS, Chicago, IL, USA).Morphologic (musclemass and
CSA) comparisons between experimental and control conditions
were assessed via 1-way between-group ANOVA. Microarray
data were analyzed for statistical comparisons via 1-way
between-group ANOVA within the TAC software. Targeted
real-time qRT-PCR was analyzed by using a 1-way between-
group ANOVA (with Tukey’s post hoc tests). DNA methylation
data sets were analyzed by using a 2-way between-group
ANOVA(withTukey’spost hoc tests),whichallowedcomparison
of experimental conditions and individual CpG islands. A
follow-up 1-way ANOVA between CpG islands at each experi-
mental condition was used to identify significant differences in
the DNAmethylation status of each CpG islandwithin the same
experimental condition. Finally, Student’s t tests were used to
identify significant differences in CpG methylation between ex-
perimental conditions and control. All statistical analyses for
DNA methylation were performed on absolute values, with
figures representing data as mean 6 SD to relevant control. Dif-
ferences were considered statistically significant at values of P#
0.05.
RESULTS
Skeletal muscle disuse and recovery evokes
considerable, yet reversible, muscle atrophy
Exposure toTTXproducedanaverageof 7.06 2.4% loss in
TAmusclemass at 3 d, 28.76 5.1% at 7 d, and 50.76 2.7%
loss after 14 d that resulted in statistical significance at all
timepoints vs. the control right TA (P, 0.001;Fig. 3) and a
significant difference between paired comparisons of 3
and7d, 3and14d, 7 and14d (P,0.001).After 14dofTTX
exposure followed by 7 d of cessation in the recovery
group, muscle mass significantly recovered by 51.7% vs.
14 d of denervation (P = 0.001; Fig. 3). Seven days of re-
covery did not completely restore muscle mass, asmuscle
mass was still significantly lower than control (P, 0.001;
Fig. 3), and total muscle mass was equivalent to levels at
7dofTTXadministration,which suggests that rates of loss
over 7 d were similar to rates of recovery. We therefore
report significant skeletal muscle atrophy of the TA mus-
cleswith disuse and a 51.7% recovery ofmusclemass after
7 d of cessation of TTX administration and the return of
normal habitual physical activity vs. 14 d of TTX induced-
denervation.
Exposure to TTX produced a progressive reduction in
mean muscle fiber CSA of 17.956 12.06% at 3 d, 42.096
6.17% at 7 d, and 68.946 2.97% at 14 d of TTX exposure,
with 7 and 14 d of TTX being significantly reduced vs.
control (P = 0.003 and P , 0.001, respectively; Fig. 4).
Similar to TA muscle mass, upon TTX cessation, the 14-d
TTX + 7-d recovery group muscle CSA significantly re-
covered compared with 14 d of TTX alone, with an in-
crease of 62.6% inCSA comparedwith 14 d of TTXalone
(P = 0.002; Fig. 4); therefore, there was significant atrophy
of individual skeletal muscle fibers in TA muscles after
denervation, and a 51.7% recovery of muscle mass and a
62.6%recoveryofmuscleCSAafter 7dof cessationofTTX
administration and a return to normal habitual physical
activity.
Gene expression microarrays identify
important gene regulatory networks involved
in muscle atrophy and recovery
After confirming a significant reduction in muscle mass,
the temporal transcriptome profile that accompanied
muscle atrophy was investigated (n = 4). The dendogram
from the hierarchical clustering of probe sets across the
genome identified 3714 genes that demonstrated highly
significant differential expression across all conditions
with a value of P # 0.001 (Fig. 5A). It also demonstrated
that there was high clustering similarity for the 3-, 7-,
and 14-d TTX groups, which were dissimilar to the
sham-surgery controls and the recovery group that also
TABLE 3. HDAC4 DNA methylation via HRM-PCR
Gene CpG no. GeneGlobe no. Chromatin location Sequence to analyze Product length (bp)
Hdac4 1 PM00599046 Chr9: 91389151–91391341 GGGCGCGCAAGAGCGCAGACTGTGAC
GGGGGCCCGGT
190
2 PM00599053 Chr9: 91390077–91391147 GCGCCCGCGAAGCGGGGGTGGCTGTT
GGGCTATTGTAGGGCGGA
138
3 PM00599060 Chr9: 91389052–91391220 GCTAGCGCCTGGAGAGTCCTCGGTAC
GCCCCGC
168
4 PM00599067 Chr9: 91389477–91391621 GCTTTGGGTCGCCGCCACCGCGTCCC
GGT
144
5 PM00599074 Chr9: 91389472–91391621 CGTTGCTGTGGCGGAGGTGTAGGCTT
TGGGTCGCCGCCACCGCGTCCCG
149
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demonstrated high clustering similarity (Fig. 5A and
Supplemental 1A). This suggested that disuse-induced
atrophy evoked a considerable change in the expression
of a large number of genes that were returned to levels
similar to those in shamcontrols on the cessation of nerve
block in the recovery group (Fig. 5A). Despite the top
20 genes showing recovery to sham control levels, 846
genes were still significantly differentially expressed
(P , 0.05) in the recovery group compared with sham
control (Supplemental 1I). Additional analyses were
performed by using unsupervised hierarchical cluster-
ing of the top 20 most differentially expressed genes
(Fig. 5B and Supplemental 2). This analysis confirmed
that these top 20 genes that were most differentially
expressed in TTX groups returned to sham control after
7 d of recovery. Furthermore, the top 500 genes thatwere
up-regulated by TTX administration could be grouped
into 3 distinct clusters on the basis of their temporal be-
havior: an immediate and sustained increase in expres-
sion (Fig. 5C), a delayed, but progressive, increase
in expression (Fig. 5D), and, finally, an immediate in-
crease in expression that declined over the time course
(Fig. 5E), which suggested that dynamic and coordi-
nated gene expression occurred across a large number of
genes as a result of disuse, and that there was a return to
control levels in the recovery group.
Regulated genes identified by microarray and
ranked by significance of change
Transcriptome-wide data were analyzed to compare condi-
tions in 6pairwise comparisons [sham vs. 3 d (Supplemental
1C), 7d (Supplemental 1D), and14d (Supplemental 1E); and
Recovery vs. 3 d (Supplemental 1F), 7 d (Supplemental 1G),
and 14 d (Supplemental 1H)] to identify the genes that were
among the most significantly affected in the experimental
groups. Trim63 (MuRF1),myogenin (MyoG), andAmpd3
were identified as being the most frequently occurring
genes that were most differentially expressed across these
paired comparisons and that also appeared in the top 20
differentially expressedgenes across all conditions (Fig. 5B
and Supplemental 1B). Ampd3 appeared in 4 of 6 of these
paired comparisons (Supplemental 1C, F–H). Previous
studieshavealso suggested thatoverexpressionofAmpd3
increases protein degradation in C2C12 myotubes (32);
therefore,we sought to further elucidate its transcriptional
and epigenetic role in denervation-induced atrophy in the
present study. The E3 ubiquitin ligase, Trim63, appeared
in 3 of 6 paired comparisons (Supplemental 1C, F,H) and
has been previously strongly associated with muscle at-
rophy in vitro and in vivo (33–37), as has been its protein
family member, Fbxo32 (Mafbx). We therefore extended
the analysis of this change by qRT-PCR and locus-specific
pyrosequencing for the role of DNA methylation in TTX-
induced atrophy and recovery. The muscle-specific basic
helix-loop-helix myogenic regulatory factor, MyoG, was
also identified in 3 of 6 paired comparisons (Supplemental
Fig. 1C–E) and has previously been identified as a key
transcript in the regulation of denervation-dependent
muscular atrophy in rodent models (38). Of importance,
the class II histone deacetylase 4 (Hdac4) also appeared
within the top 20most statistically differentially expressed
genes across all probe sets (Fig. 5B and Supplemental 1B)
andwas themost statistically differentially expressed gene
when comparing sham control with 3-d TTX atrophy
probe sets (Supplemental 1C). Hdac4 is a known upstream
regulatory factor of MyoG activity (36, 39), and, thus, both
Hdac4 and MyoG genes were identified as warranting
additional targeted analysis. Additionally, a neuromuscu-
lar junction–associated gene that was significantly altered
and that also appeared in the top 20 most differentially
expressed genes included the acetylcholine receptor sub-
unit a1 (Chrna1; Fig. 5B). This gene also appeared in 2 of 6
paired comparisons of most differentially expressed genes
(Supplemental 1D, E). Chrna1 plays a crucial role in ace-
tylcholine binding and the channel-gating activity within
the neuromuscular junction pathway (40) and has been
previously been identified via transcriptomeanalysis as the
most differentially expressed gene in skeletal muscle loss
observed in age-related muscle loss/denervation (41). Af-
ter the identification of key gene transcripts, quantification
of gene expression was elucidated via follow-up real-time
qRT-PCR to confirm and further profile the transcriptional
responses, andDNAmethylation analyseswere performed
via pyrosequencing to assess the DNAmethylation status
of the gene promoter region in response to disuse-induced
muscle atrophy and recovery.
Changes in gene expression after
disuse-induced atrophy are returned to
control levels after recovery
Confirmation ofmicroarray gene expression by qRT-PCR
demonstrated that MyoG, Hdac4, Trim63, and Fbxo32
were significantly increased at 3 d of TTX exposure
comparedwithcontrol (P,0.05),withHdac4andFbxo32
Figure 3. Quantiﬁcation of muscle atrophy (muscle mass) in
vivo after TTX-induced nerve block. Data shown for 3, 7, and
14 d of treatment, and TTX nerve block + 7 d of active recovery
(7-d recovery). Mean TA mass for all control and experimental
groups is expressed as a percentage difference of whole-
animal body mass (428 6 45 g) to normalize for interindi-
vidual differences in animal size. All data are presented as
means 6 SD for n = 6 in each condition. *P , 0.05 vs. sham
control; #P , 0.05 vs. 14-d TTX.
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(Fig. 6A) remaining elevated at 7 d of TTX exposure. By 14
d, mean levels for Hdac4, MyoG, Trim63, and Fbxo32
werenot significantlydifferent, that suggestedanelevation
of these genes at 3 and7d in response todisuse. In contrast,
whereas significant changes inAmpd3expressionwerenot
detected (Fig. 6A), Chrna1 expression was significantly
elevated at 3, 7, and 14 d (177.5-fold increase vs. control;
P = 0.016; Fig. 6A). After TTX cessation and 7 d of
recovery, it was also confirmed via qRT-PCR that Hdac4,
MyoG, Trim63, Fbxo32, and Chrna1 gene expression had
all returned to sham control levels, as demonstrated in
the microarray data.
Figure 4. Muscle ﬁber CSA after TTX-induced atrophy and
recovery. Mean CSA of the TA muscle was expressed as
percentage change from untreated contralateral control
limb for each animal. Hematoxylin and eosin–stained
sections of untreated (A) and treated (B) TA muscle of
control (i), 3-d TTX exposed (ii), 7-d TTX exposed (iii), 14-d
TTX exposed (iv), and 14-d TTX exposed with 7-d recovery
(v). *P , 0.05 vs. sham control; #P , 0.05 vs. 14-d TTX.
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Changes in DNA methylation were associated
with altered gene expression in disuse-induced
atrophy and recovery
Locus-specific pyrosequencing of individual CpG islands
within gene promoters revealed significant alterations in
the DNA methylation of key genes that were identified
after microarray analysis and confirmatory real-time qRT-
PCR that corresponded with significant increases in gene
transcription. After 3 d of TTX exposure, there was a sig-
nificant reduction (P = 0.011) of DNA methylation in the
MyoG gene promoter (Fig. 6B) and a concomitant signifi-
cant increase (P=0.011) inMyoGgene expression (Fig. 6A),
both of which then returned to baseline levels during the
remaining 14 d (all gene expression/DNA methylation
overlap relationships are schematically represented in Fig.
6C). The DNA methylation profile of the Chrna1 gene
promoter progressively decreased relative to control,
with 7 and 14 d of TTX treatment attaining significance
compared with sham control (P = 0.035 and P , 0.001,
respectively). This corresponded with the increased
expression of this gene over the 14-d denervation period
(Fig. 6A, C). As with Chrna1, Trim63 displayed a signifi-
cant reduction in methylation at 7 and 14 d of TTX expo-
sure (P = 0.035 and P , 0.001, respectively; Fig. 6B, C),
which coincided with a stable increase in mRNA expres-
sion at the same time points (Fig. 6A, C). Fbxo32 demon-
strated a decreasing trend in DNAmethylation at specific
time points, attaining significance at 14 d of TTX exposure
(P = 0.021; Fig. 6B, C), with gene expression data demon-
strating significant increases at 3 (P = 0.037) and 7 d (P =
0.038) atrophy (Fig. 6A, C). Of importance, after TTX ces-
sation, therewas recovery in theDNAmethylationprofiles
of Trim63, Fbxo32, and Chrna1, which returned to sham
control levels (P . 0.05). This was in conjunction with an
observed recovery of gene expression of the same genes
upon TTX cessation (Fig. 6C). We observed no differences
in DNAmethylation for Ampd3 after TTX administration
or recovery (Fig. 6B). Furthermore, after initial total per-
centage of methylation within the total amplicon/product
via HRM-PCR for Hdac4, we were unable to identify
methylationgreater than thatof the0%methylationcontrol
for all conditions, and, therefore, pyrosequencing for locus-
specific DNAmethylation was not performed for Hdac4.
Figure 5. Transcriptome analysis indicated a highly
dynamic gene expression response to progressive
muscular atrophy that returns to expression levels in
the sham control upon muscle recovery. A) Hierar-
chical clustering heatmaps of probe set expression
across the rodent genome identiﬁed 3714 genes that
were highly statistically signiﬁcantly (P # 0.001)
expressed across all conditions, with 3-, 7-, and 14-d
TTX atrophy being differentially expressed com-
pared with sham control and 14-d TTX + 7-d
recovery. B) This observation was conﬁrmed in
analysis of the top 20 statistically differentially
expressed genes across all conditions. Similar
clustering occurred within 3-, 7-, and 14-d of TTX
exposure which was distinctly dissimilar to the
clustering observed in the sham control and 7-day
recovery group. C–E) Top 500 most statistically
differentially expressed genes grouped into 3 distinct
temporal expression patterns: an immediate and
sustained increase in expression (C); delayed, but
progressive, increase in expression (D); or an immediate
increase in expression that declined over the time
course (E). Of note, all gene clusterings return to sham
control expression levels upon TTX cessation and 7 d
of recovery.
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Figure 6. Relative fold change of gene expression and DNA methylation of a subset of identiﬁed gene transcripts. A) Relative fold
change in mRNA expression of genes MyoG, Trim63, Fbxo32, Chrna1, Ampd3, and Hdac4 (in descending order). All genes are
presented as means 6 SD (n = 6), Ampd3 (n = 3). Statistically signiﬁcant changes in fold difference compared with sham control
group are indicated via *. Sham control group is represented with triangle icon. All TTX-treated groups are represented with a
square icon. B) Mean methylation data presented as relative fold change compared with sham control for genes: MyoG, Trim63,
Fbxo32, Chrna1, and Ampd3 (in descending order). Mean percentage data (black column bars) are the averages taken from
each CpG island of the respective gene, analyzed via locus-speciﬁc pyrosequencing. Individual CpG island methylation
(continued on next page)
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DISCUSSION
Summary
The aim of this investigation was to elucidate the epige-
netic control of gene expression after skeletal muscle
disuse-induced atrophy after 3, 7, and 14 d of nerve block
with TTX. First, we observed a 7, 29, and 51% loss of
muscle at 3, 7, and 14 d of disuse, with 7 d of recovery
resulting in a 51.7% restoration of total muscle mass that
had been lost after 14 d of disuse. Muscle mass was
therefore similar after 7 d of disuse or 14 d of disuse fol-
lowed by 7 d of normal activity. Muscle atrophy was
further confirmed with fiber cross-sectional area data in
which a similar pattern of progressive loss of 18, 42, and
69%was observed after 3, 7, and 14d of TTX, respectively.
Seven days of recovery restored 63% of muscle cross-
sectional area vs. 14 d of disuse-induced atrophy alone.
Our original hypothesis was supported, in that disuse-
induced atrophy was associated with reduced DNA
methylation and enhanced gene expression. Both DNA
methylation and gene expression were partially returned
to baseline after 7 d of recovery from nerve block. Of im-
portance, after gene expression microarray analysis, we
found that 3714 genes were significantly differentially
regulated (P# 0.001) across all TTXgroups, and that these
genes were returned in the recovery group to levels that
wereobserved in shamcontrol. Specifically, by identifying
the top 20 most differentially expressed genes in the atro-
phy and recovery groups and cross-referencing with the
most frequently occurring significantly regulated genes
for between-group pairwise comparisons, we identified a
key subset of influential genes: MyoG, Hdac4, Trim63
(Murf1), Ampd3, and Chrna1. These genes—together
with Fboxo32 (Mafbx), because of its previously defined
role with Trim63 (Murf1) in muscle atrophy—were then
analyzed via real-time qRT-PCR to confirm microarray
gene expression data for these genes, as well as locus-
specific DNA methylation of the promoter regions by
pyrosequencing. All of these genes—MyoG, Hdac4,
Trim63/Murf1, Ampd3, Chrna1, and Fboxo32/Mafbx—
have been identified previously via transcriptome-wide
analysis of disuse-induced atrophy after neuromuscular
blocker a-cobrotoxin treatment (42). In this investigation,
we have identified novel data that suggest that MyoG,
Trim63 (Murf1),Fbxo32 (Mafbx), andChrna1demonstrate
reduced DNA methylation at specific time points after
disuse-induced atrophy that corresponded with increases
in gene expression at the same time points. Of importance,
after TTX cessation and 7 d of recovery, during which
normal habitual physical activity was resumed, there was
a return of DNA methylation for Trim63, Fbxo32, and
Chrna1 to sham control levels. This also corresponded
with the return of gene expression to that of baseline sham
control levels. Because the reduced DNA methylation
within promoter or enhancer regions of genes can lead
to enhanced gene expression as a result of reduced
methylation, which allows access for RNA polymerase
to enable transcription (43), our data suggest that atrophy
and recovery of skeletal muscle after disuse is associated
with dynamic and transient epigenetic modifications that
correspond with altered gene expression.
Dynamic and transient DNA methylation after
atrophy and recovery of muscle mass
Interestingly, 51.7%of totalmusclemass loss after 14dwas
restored after 7 d of recovery, yet, importantly, gene ex-
pression was returned fully to baseline after 7 d, which
suggests—as perhaps would be expected because of the
time required for transcription, translation, and protein
incorporation—a time lag between gene expression and
the physiological restoration ofmusclemass. The findings
in this study, however, suggest that reduced DNA meth-
ylation that corresponded with increased gene expression
ofMyoG, Trim63 (MuRF1), Fbxo32 (MAFbx), and Chrna1
are dynamic and transient events, in which decreases in
DNAmethylationat 3, 7, and14dofTTX-inducedatrophy
correspondwith increases in gene expression that, in turn,
are returned to baseline (Trim63/MuRF1 and Chrna1)
within just 7 d after the removal of the TTX block. DNA
methylationhaspreviouslybeen reported tobemitotically
stable and, as such, environmental factorswerepreviously
believed to be unable to induce significant alterations in
DNA methylation at both acute and chronic time points
(44). Furthermore, our previous data suggest that even
after acute catabolic stress,DNAmethylation canbe stably
retained across several population doublings of muscle
cells in vitro (24); however,wedemonstrate here thatDNA
methylation does respond at a rate that allows for its
participation in the adaptive control of gene expression
and therefore adds additional weight to previous findings
in support of transient alterations of DNAmethylation in
skeletal muscle, for example, as previously after an acute
bout of aerobic exercise (24, 45). Our data therefore add
support to previous findings demonstrating transient al-
terations of skeletal muscle DNAmethylation.
Although not identified in this study, it will be impor-
tant in future studies to investigateDNAmethyltransferase
activity. The DNA methyltransferases (DNMT3a/3b)
are involved in the initial incorporation ofmethyl groups
to cytosine residues and the creation of 5-methylcytoseine
to increase DNA methylation. Maintenance DNA meth-
yltransferase (DNMT1) is involved in retaining themethyl
tag on the DNA strand (46). The dynamic and transient
observation of DNAmethylation in this study is perhaps
percentages are visualized as individual lines. DNA methylation data presented as means 6 SD for n = 3. *P , 0.05 vs. sham
control group; §P , 0.05 vs. 7- and 14-d TTX atrophy; ✢P , 0.05 for DNA methylation vs. 3-d TTX–exposed experimental
group. C ) An overlap schematic represents the relationship between DNA methylation and mRNA expression of key
transcripts (arbitrary units). bHLH muscle speciﬁc basic helix-loop-helix; H&E, hematoxylin and eosin; MRF, myogenic
regulatory factor.
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suggestive of high DNMT3a/3b activity in which initial
and rapid increases in DNA methylation are observed;
however, we do not report a significant retention of DNA
methylation upon TTX cessation (14-d TTX + 7-d re-
covery), which would perhaps suggest that DNMT1 did
notmaintain themethylation statusof someof thesegenes
during muscle recovery. It has previously been reported
that increases in both types of DNMT are observed after a
high-fatdiet that induces increases inDNAmethylationof
6508 genes (47). Additional work is needed to confirm
similar findings in atrophyingmuscle and to elucidate the
response of DNAmethyltransferases upon the reversible
insult. Finally, it would be important to undertake 14 d of
recovery in future experiments to assess whether muscle
mass canbe returned fully tobaseline control levels and to
examine the transcriptomic and epigenetic responses
during this period.
DNA methylation correlates with important
changes in skeletal muscle gene expression
after disuse-induced atrophy and with the
return of gene expression to baseline
during recovery
As suggested above, MyoG, Trim63, Fbxo32, and Chrna1
demonstrated decreased DNA methylation after disuse-
induced atrophy that corresponded with increased gene
expression. Of importance, after TTX cessation and 7 d of
recovery, during which normal habitual physical activity
was resumed, DNA methylation of Trim63 and Chrna1
returned to sham control levels as the supressed levels of
gene expression recovered. The muscle-specific basic
helix-loop-helix transcriptional factor and member of the
myogenic regulatory factors, MyoG, is commonly associ-
atedwith the coordination of skeletalmuscle development/
myogenesis or skeletal muscle regeneration and, specifi-
cally, the differentiation/fusion of skeletalmuscle cells (48).
Here, we report a significant induction of gene expression
for this transcription factor upon disuse-induced muscle
atrophy. Because expression of this protein is usually as-
sociated with muscle regeneration, this may reflect a com-
pensatory mechanism in an unsuccessful attempt to halt
atrophy or to respond to a return of activity. The role of
MyoG as a transcription factor has previously been linked
with the regulation of the ubiquitin E3 ligases, Trim63 and
Fbxo32, and associated muscle atrophy (34). We provide
novel data that suggest that theDNAmethylationprofile of
this transcript is altered in an inverse fashion to its mRNA
expression. Indeed, at 3, 7, and 14 d, we observed a signif-
icant reduction inMyoGDNAmethylation and an increase
in MyoG transcript expression; therefore, we suggest that
increased MyoG gene expression is regulated by reduced
MyoG DNAmethylation.
Previous studies have also reported that MyoG gene
expression is under the regulatory control of class II Hdacs
(34, 35). In partial support of this notion, we report a sig-
nificant increase in Hdac4 gene expression at 3 and 14 d
of TTX exposure; however, we did not measure protein
abundance or the phosphorylation/deacetylation status
of Hdac4. Indeed, the initial screening of Hdac4 DNA
methylation viaHRM-PCRwas unable to detect a notable
change, with global gene percentage methylation indi-
cating no methylation above 0% methylated controls.
Therefore, additionalworkat theprotein andhistone levels
is needed to elucidate the epigenetic regulation of Hdacs
during periods of loss and recovery of muscle mass, as its
altered gene expression after denervation does not seem to
be controlled viaDNAmethylation. Furthermore, despite a
return of MyoG gene expression to control levels after
7 d of recovery, DNA methylation continued to reduce
in the recovery group. This suggested that while reduced
DNAmethylation may have been important in increased
gene expression during denervation-induced atrophy,
DNAmethylationwas not controlling the gene expression
of MyoG during recovery.
As previously suggested, downstream transcriptional
targets of MyoG have also been shown to be highly in-
duced in rodents during periods of muscle loss caused by
denervation, immobilization, and unloading (49, 50).
Trim63 is anE3ubiquitin ligase and amember of theRING
zinc finger family of proteins that directs the poly-
ubiquitination of proteins to target them for proteolysis.
With catabolic stimuli, such as diabetes, cancer, denerva-
tion, unloading, and glucocorticoid or cytokine treatment,
its expression has consistently been demonstrated to in-
crease (50, 51). Previous studies have also suggested that
upon denervation, Northern blot analysis identified a sig-
nificant increase in Trim63 and Fbxo32 after 3 d of muscle
atrophy, that continued through to7d (50).Here,we report
a significant increase in Trim63 and Fbxo32 gene expres-
sion via real-timeqRT-PCRcomparedwith control levels in
parallel with a reduction in DNA methylation. This sug-
gests an important role for epigenetic control of these
ubiquitin ligases in the resulting protein degradation and
muscle loss that has been observed in this study. We note
that DNA methylation of both of these ubiquitin ligases
increased to control levelswith corresponding decreases in
gene expression to the sham control level, which also
suggests that the reductions in DNA methylation during
atrophy can be dynamically regulated.
Furthermore, Chrna1 makes up the majority of the
muscle-specific nicotinic acetyl choline receptor (nAChR)
in adult skeletal muscle (52) and plays a crucial role in
initiating the opening of the nAChR channels and the
transfer of positively charged ions (53). We reported a
progressive increase in gene expression resulting in a cu-
mulative significant fold change after 14 d of TTX expo-
sure. This alteration in gene expression was met with a
parallel progressive reduction in DNA methylation with
significance being observed at both 7 and 14 d after TTX-
inducedatrophy.Anobservation similar topreviouswork
(54), inwhich a significant increase in Chrna1 activitywas
observedasa result of sarcopenia.nAChRsaremadeupof
5 isoforms in human skeletal muscle, inwhich the subunit
Chrna1 is most dominant. These isoforms function to
create an acetylcholine cluster around the neuromuscular
central pore, in which they house target binding sites
predominantly locatedat thea-subunit in the extracellular
domain near the N terminus. Upon contact of a chemical
messenger to the binding site, all present subunits un-
dergo a conformational change that results in the opening
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of the nAChR channel (55). Upon denervation, however,
no actionpotentialmessages are received and, therefore, it
is possible that the reduced DNA methylation and in-
creased transcriptional response—although we do not
provide evidence of protein levels—may increase as a
compensatory mechanism that is understood to increase
the chance of forming new end plates. This response is
equivalent to that observed after nerve section and it
seems, therefore, to be a response to the lack of activity
rather than the physical absence or damage to the nerve.
Further, upon TTX cessation and muscle recovery, we
report a return of Chrna1 DNA methylation and gene
expression back towards sham control levels.
Finally, it is important to note that MyoG, ubiquitin
ligases, and Chrna1 have been identified as major regu-
lators of muscle regeneration, protein degradation, and
function, respectively, and that the present study identi-
fied these genes as being the most frequently occurring,
differentially expressed genes across comparisons by us-
ing anonselective transcriptome-wide approach in anovel
model of osmotically administered TTX-induced atrophy.
Therefore, these data further consolidate the important
role for epigenetics in the regulation of these genes in
disuse-induced atrophy and the recovery of skeletal
muscle following a return to activity.
CONCLUSIONS
MyoG, Trim63, Fbxo32, and Chrna1, but not Ampd3,
demonstrate decreased DNA methylation after disuse-
induced atrophy that correspond with increased gene
expression and muscle atrophy. Importantly, after TTX ces-
sation and 7 d of recovery, there was increased DNA
methylation of Trim63 and Chrna1 to control levels that
also corresponded with the return of gene expression to
that of baseline in shamcontrols.Overall, this suggests that
the atrophy and recovery of skeletal muscle after disuse is
controlled by the dynamic and transient epigenetic regu-
lation of gene expression.
ACKNOWLEDGMENTS
This work was supported by an integrative mammalian
biology studentship from the UK Medical Research Council
[to A.G.F. (via J.C.J.)], as well as by a Doctoral Training
Alliance funded studentship and GlaxoSmithKline [to R.A.S.
(via A.P.S.)]. The authors declare no conﬂicts of interest.
AUTHOR CONTRIBUTIONS
A. G. Fisher, R. A. Seaborne, J. M. Coulson, A. P. Sharples,
and J. C. Jarvis designed research; A. G. Fisher, R. A.
Seaborne, T. M. Hughes, A. Gutteridge, C. Stewart, J. M.
Coulson, A. P. Sharples, and J.C. Jarvis analyzeddata;A.G.
Fisher, R. A. Seaborne, J. M. Coulson, A. P. Sharples, and
J. C. Jarvis performed research; A. G. Fisher, R. A. Seaborne,
C. Stewart, A. P. Sharples, and J. C. Jarvis wrote the paper;
and T. M. Hughes contributed analytic tools.
REFERENCES
1. Ferrando, A. A., Lane, H. W., Stuart, C. A., Davis-Street, J., andWolfe,
R. R. (1996) Prolonged bed rest decreases skeletal muscle and whole
body protein synthesis. Am. J. Physiol. 270, E627–E633
2. LeBlanc,A.D., Schneider,V. S.,Evans,H. J., Pientok,C.,Rowe,R., and
Spector, E. (1992) Regional changes in muscle mass following 17
weeks of bed rest. J. Appl. Physiol. (1985) 73, 2172–2178
3. Gibson, J. N., Halliday, D., Morrison, W. L., Stoward, P. J., Hornsby,
G. A., Watt, P.W., Murdoch, G., and Rennie,M. J. (1987) Decrease in
human quadriceps muscle protein turnover consequent upon leg
immobilization. Clin. Sci. (Lond.) 72, 503–509
4. Deitrick, J. E. (1948) The effect of immobilization on metabolic and
physiological functions of normal men. Bull. N. Y. Acad. Med. 24,
364–375
5. Acharyya, S., Ladner, K. J., Nelsen, L. L., Damrauer, J., Reiser, P. J.,
Swoap,S., andGuttridge,D.C. (2004)Cancer cachexia is regulatedby
selective targeting of skeletalmuscle geneproducts. J. Clin. Invest. 114,
370–378
6. Tan,B.H., andFearon,K.C. (2008)Cachexia: prevalence and impact
in medicine. Curr. Opin. Clin. Nutr. Metab. Care 11, 400–407
7. Hasselgren, P. O., and Fischer, J. E. (1998) Sepsis: stimulation of
energy-dependent protein breakdown resulting in protein loss in
skeletal muscle.World J. Surg. 22, 203–208
8. Strassburg, S., Springer, J., and Anker, S. D. (2005)Muscle wasting in
cardiac cachexia. Int. J. Biochem. Cell Biol. 37, 1938–1947
9. Kalyani, R. R., Corriere, M., and Ferrucci, L. (2014) Age-related and
disease-related muscle loss: the effect of diabetes, obesity, and other
diseases. Lancet Diabetes Endocrinol. 2, 819–829
10. Giangregorio, L., and McCartney, N. (2006) Bone loss and muscle
atrophy in spinal cord injury: epidemiology, fracture prediction, and
rehabilitation strategies. J. Spinal Cord Med. 29, 489–500
11. Janssen, I., Heymsﬁeld, S. B., andRoss, R. (2002)Low relative skeletal
muscle mass (sarcopenia) in older persons is associated with
functional impairment and physical disability. J. Am. Geriatr. Soc. 50,
889–896
12. Batt, J., Bain, J., Goncalves, J., Michalski, B., Plant, P., Fahnestock, M.,
and Woodgett, J. (2006) Differential gene expression proﬁling of
short and long term denervated muscle. FASEB J. 20, 115–117
13. Dupont Salter,A.C.,Richmond,F. J., andLoeb,G.E. (2003)Effects of
muscle immobilization at different lengths on tetrodotoxin-induced
disuse atrophy. IEEE Trans. Neural Syst. Rehabil. Eng. 11, 209–217
14. De Boer, M. D., Maganaris, C. N., Seynnes, O. R., Rennie, M. J., and
Narici, M. V. (2007) Time course of muscular, neural and tendinous
adaptations to 23 day unilateral lower-limb suspension in youngmen.
J. Physiol. 583, 1079–1091
15. Nikawa, T., Ishidoh, K., Hirasaka, K., Ishihara, I., Ikemoto, M., Kano,
M.,Kominami,E.,Nonaka, I.,Ogawa,T.,Adams,G.R.,Baldwin,K.M.,
Yasui, N., Kishi, K., and Takeda, S. (2004) Skeletal muscle gene
expression in space-ﬂown rats. FASEB J. 18, 522–524
16. Jarvis, J. C., and Salmons, S. (1991) A family of neuromuscular
stimulators with optical transcutaneous control. J. Med. Eng. Technol.
15, 53–57
17. Jarvis, J. C., Mokrusch, T., Kwende, M. M., Sutherland, H., and
Salmons, S. (1996) Fast-to-slow transformation in stimulated rat
muscle.Muscle Nerve 19, 1469–1475
18. Bonaldo, P., and Sandri, M. (2013) Cellular and molecular
mechanisms of muscle atrophy. Dis. Model. Mech. 6, 25–39
19. Eddins, M. J., Varadan, R., Fushman, D., Pickart, C. M., and
Wolberger, C. (2007) Crystal structure and solution NMR studies of
Lys48-linked tetraubiquitin at neutral pH. J. Mol. Biol. 367, 204–211
20. Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A.,
Walsh, K., Schiafﬁno, S., Lecker, S. H., and Goldberg, A. L. (2004)
Foxo transcription factors induce the atrophy-related ubiquitin ligase
atrogin-1 and cause skeletal muscle atrophy. Cell 117, 399–412
21. Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey,
J., Price, S. R.,Mitch,W. E., andGoldberg, A. L. (2004)Multiple types
of skeletal muscle atrophy involve a common program of changes in
gene expression. FASEB J. 18, 39–51
22. Jaenisch, R., and Bird, A. (2003) Epigenetic regulation of gene
expression: how the genome integrates intrinsic and environmental
signals. Nat. Genet. 33 (Suppl), 245–254
23. Magnusson, C., Svensson, A., Christerson, U., and Ta˚gerud, S. (2005)
Denervation-inducedalterations ingeneexpression inmouse skeletal
muscle. Eur. J. Neurosci. 21, 577–580
24. Sharples, A. P., Polydorou, I., Hughes, D. C., Owens, D. J., Hughes,
T. M., and Stewart, C. E. (2016) Skeletal muscle cells possess a
EPIGENETICS OF GENE EXPRESSION IN MUSCLE ATROPHY 5281
Downloaded from www.fasebj.org by (2.126.253.197) on December 01, 2018. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 5268-5282.
‘memory’ of acute early life TNF-a exposure: role of epigenetic
adaptation. Biogerontology 17, 603–617
25. Sharples,A.P., Stewart,C.E., andSeaborne,R.A. (2016)Does skeletal
muscle have an ‘epi’-memory? The role of epigenetics in nutritional
programming, metabolic disease, aging and exercise. Aging Cell 15,
603–616
26. Ehrlich, K. C., Paterson,H. L., Lacey,M., andEhrlich,M. (2016)DNA
hypomethylation in intragenic and intergenic enhancer chromatinof
muscle-speciﬁc genes usually correlates with their expression. Yale J.
Biol. Med. 89, 441–455
27. Buffelli, M., Pasino, E., and Cangiano, A. (1997) Paralysis of rat
skeletal muscle equally affects contractile properties as does
permanent denervation. J. Muscle Res. Cell Motil. 18, 683–695
28. Michel, R. N., and Gardiner, P. F. (1990) To what extent is hindlimb
suspension a model of disuse?Muscle Nerve 13, 646–653
29. Irizarry, R. A., Bolstad, B. M., Collin, F., Cope, L. M., Hobbs, B., and
Speed, T. P. (2003) Summaries of affymetrix geneChip probe level
data. Nucleic Acids Res. 31, e15
30. Irizarry, R. A., Hobbs, B., Collin, F., Beazer-Barclay, Y. D., Antonellis,
K. J., Scherf, U., and Speed, T. P. (2003) Exploration, normalization,
and summaries ofhighdensity oligonucleotide array probe level data.
Biostatistics 4, 249–264
31. Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR
data by the comparative CT method. Nat. Protoc. 3, 1101–1108
32. Davis, P., Witczak, C., and Brault, J. (2015) AMP deaminase 3
accelerates protein degradation in C2C12 myotubes. FASEB J. 29
33. Cohen, S., Brault, J. J., Gygi, S. P., Glass, D. J., Valenzuela, D. M.,
Gartner, C., Latres, E., and Goldberg, A. L. (2009) During
muscle atrophy, thick, but not thin, ﬁlament components are
degraded by MuRF1-dependent ubiquitylation. J. Cell Biol. 185,
1083–1095
34. Cohen,T. J.,Waddell,D. S., Barrientos, T., Lu, Z., Feng,G.,Cox,G.A.,
Bodine, S. C., and Yao, T. P. (2007) The histone deacetylase HDAC4
connects neural activity to muscle transcriptional reprogramming.
J. Biol. Chem. 282, 33752–33759
35. Tang, H., and Goldman, D. (2006) Activity-dependent gene regula-
tion in skeletal muscle is mediated by a histone deacetylase (HDAC)-
Dach2-myogenin signal transduction cascade. Proc. Natl. Acad. Sci.
USA 103, 16977–16982
36. Tang,H.,Macpherson,P.,Marvin,M.,Meadows,E.,Klein,W.H.,Yang,
X. J., and Goldman, D. (2009) A histone deacetylase 4/myogenin
positive feedback loop coordinates denervation-dependent gene in-
duction and suppression.Mol. Biol. Cell 20, 1120–1131
37. Tang, W. W., Dietmann, S., Irie, N., Leitch, H. G., Floros, V. I.,
Bradshaw, C. R., Hackett, J. A., Chinnery, P. F., and Surani, M. A.
(2015)A unique gene regulatory network resets the human germline
epigenome for development. Cell 161, 1453–1467
38. Macpherson, P. C. D., Wang, X., and Goldman, D. (2011) Myogenin
regulates denervation-dependent muscle atrophy in mouse soleus
muscle. J. Cell. Biochem. 112, 2149–2159
39. Moresi, V., Williams, A. H., Meadows, E., Flynn, J. M., Potthoff, M. J.,
McAnally, J., Shelton, J. M., Backs, J., Klein, W. H., Richardson, J. A.,
Bassel-Duby, R., and Olson, E. N. (2010) Myogenin and class II
HDACs control neurogenicmuscle atrophy by inducing E3 ubiquitin
ligases. Cell 143, 35–45
40. Yu, X. M., and Hall, Z. W. (1991) Extracellular domains mediating
epsilon subunit interactions of muscle acetylcholine receptor.Nature
352, 64–67
41. Ibebunjo, C., Chick, J. M., Kendall, T., Eash, J. K., Li, C., Zhang, Y.,
Vickers, C.,Wu, Z., Clarke, B. A., Shi, J., Cruz, J., Fournier, B., Brachat,
S., Gutzwiller, S., Ma, Q., Markovits, J., Broome, M., Steinkrauss, M.,
Skuba,E.,Galarneau, J.R.,Gygi, S. P., andGlass,D. J. (2013)Genomic
and proteomic proﬁling reveals reducedmitochondrial function and
disruptionof theneuromuscular junctiondriving rat sarcopenia.Mol.
Cell. Biol. 33, 194–212
42. Llano-Diez, M., Gustafson, A.-M., Olsson, C., Goransson, H., and
Larsson, L. (2011)Muscle wasting and the temporal gene expression
pattern in a novel rat intensive care unitmodel.BMCGenomics 12, 602
43. Bogdanovic´, O., and Veenstra, G. J. (2009) DNA methylation and
methyl-CpG binding proteins: developmental requirements and
function. Chromosoma 118, 549–565
44. Reik,W., Dean,W., andWalter, J. (2001) Epigenetic reprogramming
in mammalian development. Science 293, 1089–1093
45. Barre`s, R., Yan, J., Egan, B., Treebak, J. T., Rasmussen, M., Fritz, T.,
Caidahl, K., Krook, A., O’Gorman, D. J., and Zierath, J. R. (2012)
Acute exercise remodels promoter methylation in human skeletal
muscle. Cell Metab. 15, 405–411
46. Trasler, J., Deng, L., Melnyk, S., Pogribny, I., Hiou-Tim, F., Sibani, S.,
Oakes, C., Li, E., James, S. J., and Rozen, R. (2003) Impact of Dnmt1
deﬁciency, with and without low folate diets, on tumor numbers and
DNA methylation in Min mice. Carcinogenesis 24, 39–45
47. Jacobsen, S. C., Brøns, C., Bork-Jensen, J., Ribel-Madsen, R., Yang, B.,
Lara, E., Hall, E., Calvanese, V., Nilsson, E., Jørgensen, S. W.,
Mandrup, S., Ling, C., Fernandez, A. F., Fraga, M. F., Poulsen, P., and
Vaag,A. (2012)Effectsof short-termhigh-fat overfeedingongenome-
wide DNA methylation in the skeletal muscle of healthy young men.
Diabetologia 55, 3341–3349
48. LeGrand, F., andRudnicki,M.A. (2007) Skeletalmuscle satellite cells
and adult myogenesis. Curr. Opin. Cell Biol. 19, 628–633
49. Bodine, S. C., and Baehr, L. M. (2014) Skeletal muscle atrophy and
the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am. J. Physiol.
Endocrinol. Metab. 307, E469–E484
50. Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K., Nunez, L., Clarke,
B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., Pan,
Z. Q., Valenzuela, D. M., DeChiara, T. M., Stitt, T. N., Yancopoulos,
G. D., and Glass, D. J. (2001) Identiﬁcation of ubiquitin ligases
required for skeletal muscle atrophy. Science 294, 1704–1708
51. Goldberg, A. L. (1969) Protein turnover in skeletal muscle. II. Effects
of denervation and cortisone on protein catabolism in skeletal
muscle. J. Biol. Chem. 244, 3223–3229
52. Giniatullin, R., Nistri, A., and Yakel, J. L. (2005) Desensitization of
nicotinic ACh receptors: shaping cholinergic signaling. Trends
Neurosci. 28, 371–378
53. Beker, F., Weber,M., Fink, R. H., and Adams, D. J. (2003)Muscarinic
and nicotinic ACh receptor activation differentially mobilize Ca2+ in
rat intracardiac ganglion neurons. J. Neurophysiol. 90, 1956–1964
54. Ibebunjo,C. (2013)Genomic andproteomicproﬁling reveals reduced
mitochondrial function and disruption of the neuromuscular junction
driving rat sarcopenia.Mol. Cell. Biol. 33, 194–212
55. Colquhoun, D., and Sivilotti, L. G. (2004) Function and structure in
glycine receptors and some of their relatives. Trends Neurosci. 27,
337–344
Received for publication March 15, 2017.
Accepted for publication July 25, 2017.
5282 Vol. 31 December 2017 FISHER ET AL.The FASEB Journal x www.fasebj.org
Downloaded from www.fasebj.org by (2.126.253.197) on December 01, 2018. The FASEB Journal Vol. ${article.issue.getVolume()}, No. ${article.issue.getIssueNumber()}, pp. 5268-5282.
